StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY)
Research analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “hold” rating on the stock. Separately, Ascendiant Capital Markets decreased their target price on NovaBay Pharmaceuticals from $8.00 to $0.85 and set a “buy” rating on […]
Research analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “hold” rating on the stock. Separately, Ascendiant Capital Markets decreased their target price on NovaBay Pharmaceuticals from $8.00 to $0.85 and set a “buy” rating on […]
